{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T12:06:34Z","timestamp":1743941194745},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,28]]},"DOI":"10.7759\/cureus.22710","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T22:05:10Z","timestamp":1646085910000},"source":"Crossref","is-referenced-by-count":3,"title":["Different Course of SARS-CoV-2 Infection in Two Adolescents With Other Immunosuppressive Factors"],"prefix":"10.7759","author":[{"given":"Karolina","family":"Kuczborska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Buda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz B","family":"Ksi\u0105\u017cyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.629240","article-title":"COVID-19 in immunosuppressed children","volume":"9","author":"Nicastro E","year":"2021","unstructured":"Nicastro E, Verdoni L, Bettini LR, et al.. COVID-19 in immunosuppressed children. Front Pediatr. 2021, 9:629240. 10.3389\/fped.2021.629240","journal-title":"Front Pediatr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01181-0","article-title":"Severity of COVID-19 in children with cancer: report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project","volume":"124","author":"Millen GC","year":"2021","unstructured":"Millen GC, Arnold R, Cazier JB, et al.. Severity of COVID-19 in children with cancer: report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project. Br J Cancer. 2021, 124:754-9. 10.1038\/s41416-020-01181-0","journal-title":"Br J Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28843","article-title":"Characterization of COVID-19 disease in pediatric oncology patients: the New York-New Jersey regional experience","volume":"68","author":"Madhusoodhan PP","year":"2021","unstructured":"Madhusoodhan PP, Pierro J, Musante J, et al.. Characterization of COVID-19 disease in pediatric oncology patients: the New York-New Jersey regional experience. Pediatr Blood Cancer. 2021, 68:e28843. 10.1002\/pbc.28843","journal-title":"Pediatr Blood Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwaa158","article-title":"HIV and COVID-19: intersecting epidemics with many unknowns","volume":"190","author":"Lesko CR","year":"2021","unstructured":"Lesko CR, Bengtson AM. HIV and COVID-19: intersecting epidemics with many unknowns. Am J Epidemiol. 2021, 190:10-16. 10.1093\/aje\/kwaa158","journal-title":"Am J Epidemiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1101\/2021.04.05.21254938","article-title":"Impact of HIV infection on COVID-19 outcomes among hospitalized adults in the U.S. [PREPRINT]","author":"Durstenfeld MS","year":"2021","unstructured":"Durstenfeld MS, Sun K, Ma Y, et al.. Impact of HIV infection on COVID-19 outcomes among hospitalized adults in the U.S. [PREPRINT]. medRxiv. 2021, 10.1101\/2021.04.05.21254938","journal-title":"medRxiv"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26321","article-title":"HIV\/SARS-CoV-2 coinfection: a global perspective","volume":"93","author":"Kanwugu ON","year":"2021","unstructured":"Kanwugu ON, Adadi P. HIV\/SARS-CoV-2 coinfection: a global perspective. J Med Virol. 2021, 93:726-32. 10.1002\/jmv.26321","journal-title":"J Med Virol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28410","article-title":"Children with cancer in the time of COVID-19: an 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy","volume":"67","author":"Ferrari A","year":"2020","unstructured":"Ferrari A, Zecca M, Rizzari C, et al.. Children with cancer in the time of COVID-19: an 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy. Pediatr Blood Cancer. 2020, 67:e28410. 10.1002\/pbc.28410","journal-title":"Pediatr Blood Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10215125","article-title":"COVID-19 in children with Down syndrome: data from the Trisomy 21 Research Society Survey","volume":"10","author":"Emes D","year":"2021","unstructured":"Emes D, H\u00fcls A, Baumer N, et al.. COVID-19 in children with Down syndrome: data from the Trisomy 21 Research Society Survey. J Clin Med. 2021, 10:5125. 10.3390\/jcm10215125","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5893242","article-title":"Multiple organ failure associated with SARS-CoV-2 infection in a child with Down syndrome: is Trisomy 21 associated with an unfavourable clinical course?","volume":"2021","author":"Vazquez-Hern\u00e1ndez PI","year":"2021","unstructured":"Vazquez-Hern\u00e1ndez PI, C\u00e1rdenas-Conejo A, Catal\u00e1n-Ruiz MA, et al.. Multiple organ failure associated with SARS-CoV-2 infection in a child with Down syndrome: is Trisomy 21 associated with an unfavourable clinical course?. Case Rep Pediatr. 2021, 2021:5893242. 10.1155\/2021\/5893242","journal-title":"Case Rep Pediatr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2011.02077.x","article-title":"Respiratory problems in children with Down syndrome","volume":"48","author":"Pandit C","year":"2012","unstructured":"Pandit C, Fitzgerald DA. Respiratory problems in children with Down syndrome. J Paediatr Child Health. 2012, 48:E147-52. 10.1111\/j.1440-1754.2011.02077.x","journal-title":"J Paediatr Child Health"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann M","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, et al.. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020, 181:271-280.e8. 10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100019","article-title":"Down syndrome and COVID-19: a perfect storm?","volume":"1","author":"Espinosa JM","year":"2020","unstructured":"Espinosa JM. Down syndrome and COVID-19: a perfect storm?. Cell Rep Med. 2020, 1:100019. 10.1016\/j.xcrm.2020.100019","journal-title":"Cell Rep Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4274\/balkanmedj.galenos.2020.2020.4.43","article-title":"Childhood rheumatic diseases and COVID-19 pandemic: an intriguing linkage and a new horizon","volume":"37","author":"Ha\u015flak F","year":"2020","unstructured":"Ha\u015flak F, Y\u0131ld\u0131z M, Adrovic A, Barut K, Kasap\u00e7opur \u00d6. Childhood rheumatic diseases and COVID-19 pandemic: an intriguing linkage and a new horizon. Balkan Med J. 2020, 37:184-8. 10.4274\/balkanmedj.galenos.2020.2020.4.43","journal-title":"Balkan Med J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04663-9","article-title":"Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19","volume":"40","author":"Koker O","year":"2020","unstructured":"Koker O, Demirkan FG, Kayaalp G, et al.. Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19. Rheumatol Int. 2020, 40:1613-23. 10.1007\/s00296-020-04663-9","journal-title":"Rheumatol Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04612-6","article-title":"Implications of COVID-19 in pediatric rheumatology","volume":"40","author":"Batu ED","year":"2020","unstructured":"Batu ED, \u00d6zen S. Implications of COVID-19 in pediatric rheumatology. Rheumatol Int. 2020, 40:1193-213. 10.1007\/s00296-020-04612-6","journal-title":"Rheumatol Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2295","article-title":"Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients: a systematic review and meta-analysis","author":"Peng J","year":"2021","unstructured":"Peng J, Fu M, Mei H, et al.. Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients: a systematic review and meta-analysis. Rev Med Virol. 2021, e2295. 10.1002\/rmv.2295","journal-title":"Rev Med Virol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00216-2","article-title":"Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis","volume":"3","author":"Kyriazopoulou E","year":"2021","unstructured":"Kyriazopoulou E, Huet T, Cavalli G, et al.. Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis. Lancet Rheumatol. 2021, 3:e690-7. 10.1016\/S2665-9913(21)00216-2","journal-title":"Lancet Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jped.2020.07.001","article-title":"COVID-19 and obesity in childhood and adolescence: a clinical review","volume":"96","author":"Nogueira-de-Almeida CA","year":"2020","unstructured":"Nogueira-de-Almeida CA, Del Ciampo LA, Ferraz IS, Del Ciampo IR, Contini AA, Ued FD. COVID-19 and obesity in childhood and adolescence: a clinical review. J Pediatr (Rio J). 2020, 96:546-58. 10.1016\/j.jped.2020.07.001","journal-title":"J Pediatr (Rio J)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047659","article-title":"Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms","volume":"142","author":"Sattar N","year":"2020","unstructured":"Sattar N, McInnes IB, McMurray JJ. Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation. 2020, 142:4-6. 10.1161\/CIRCULATIONAHA.120.047659","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/srep11362","article-title":"Obesity-induced adipokine imbalance impairs mouse pulmonary vascular endothelial function and primes the lung for injury","volume":"5","author":"Shah D","year":"2015","unstructured":"Shah D, Romero F, Duong M, et al.. Obesity-induced adipokine imbalance impairs mouse pulmonary vascular endothelial function and primes the lung for injury. Sci Rep. 2015, 5:11362. 10.1038\/srep11362","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/86899-different-course-of-sars-cov-2-infection-in-two-adolescents-with-other-immunosuppressive-factors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:56Z","timestamp":1707507596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/86899-different-course-of-sars-cov-2-infection-in-two-adolescents-with-other-immunosuppressive-factors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.22710","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,28]]}}}